World Drug Safety Congress Europe

Visit the Aixial team at the World Drug Safety Congress in Amsterdam.

The World Drug Safety Congress Europe gathers over 1800 attendees to tackle the biggest challenges for safety professionals. We are thrilled to be part of this key event, which is an important platform for knowledge sharing, discussing the future of pharmacovigilance and showing how our expertise can help companies navigate a complex regulatory world.

Our team is ready to connect. You will have the opportunity to meet our experts, Saqib Mir (Director, Medical Writing and Regulatory Affairs) and Aida-Elena Avram (Associate Director, Medical Services), and our business representatives, Celia Rodriguez and Denitza Christova. They will be sharing their insights and exploring how our solutions can help streamline your operations and improve patient safety!

Key highlights of our expertise include:

• 100% oncology-experienced team
• 15 years: average experience of our team members in clinical trial delivery
• 306 oncology trials, including solid tumours, hematologic malignancies, rare and orphan indications
• Experience across Phases I–IV, in both adult and pediatric populations
• Products include drugs, devices, and combinations via various administration routes such as oral, IV, intratumoral, intralesional, etc.
• Global trial locations across APAC, Europe, LATAM, and North America